CD40 Ligand Promotes Mac-1 Expression, Leukocyte Recruitment, and Neointima Formation after Vascular Injury-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD40 Ligand Promotes Mac-1 Expression, Leukocyte Recruitment, and Neointima Formation after Vascular Injury

Published:2008-04 Issue:4 Volume:172 Page:1141-1152
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Li Guohong,Sanders John M.,Bevard Melissa H.,Sun ZhiQi,Chumley James W.,Galkina Elena V.,Ley Klaus,Sarembock Ian J.

Funder

National Institutes of Health

American Heart Association

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference63 articles.

1. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells;Henn;Nature,1998

2. Reduction of atherosclerosis in mice by inhibition of CD40 signalling;Mach;Nature,1998

3. Requirement for CD154 in the progression of atherosclerosis;Lutgens;Nat Med,1999

4. Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype;Lutgens;Proc Natl Acad Sci USA,2000

5. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice;Schonbeck;Proc Natl Acad Sci USA,2000

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NET-(works) in arterial and venous thrombo-occlusive diseases;Frontiers in Cardiovascular Medicine;2023-05-22

2. Platelet-neutrophil interaction in COVID-19 and vaccine-induced thrombotic thrombocytopenia;Frontiers in Immunology;2023-05-19

3. Novel Functions of Integrins as Receptors of CD154: Their Role in Inflammation and Apoptosis;Cells;2022-05-25

4. The Inhibition of CD40/CD154 Costimulatory Signaling in the Prevention of Renal Transplant Rejection in Nonhuman Primates: A Systematic Review and Meta Analysis;Frontiers in Immunology;2022-04-07

5. Soluble CD40 ligand and outcome in patients with coronary artery disease undergoing percutaneous coronary intervention;Clinical Chemistry and Laboratory Medicine (CCLM);2021-11-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3